BRIANA KERTESZ: Open Payments
NPI 1457366148 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 15 payments from 7 companies in 2025. Trend: 2023 $589 · 2024 $382 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $167 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| PFIZER INC. | 2 | $52 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Ozempic, PREVNAR 20, AIRSUPRA, SAPIEN 3 Ultra RESILIA, Rybelsus, CAPVAXIVE, FARXIGA, MOUNJARO.
Industry payments across AZ — which companies pay providers there.
